We would love to hear your thoughts about our site and services, please take our survey here.
Milciclib could well be a real springboard to get things rolling successfully. Can't wait for the next year here, very exciting times!
Significantly cut though Kew I believe
Some skin still in the game though
You're welcome cloudy
Looks like it might exist. Don't forget those historical grades. More still to come from sunny Nevada. A good morning indeed!
Sanji nice to see you back. Was stated in the call that there will be more added once safety data out? (Which any scientifically orientated person can already work out) Long hold. All in my humble opinion.
Couldn't agree more chaps. Good to see LTH's posting some good opinions here. I still think we're in for an interesting year. Don't forget the NAS raise option is in place at a minimum (I think a minimum) £1.50 a share and max £100m in one go. Could see something really interesting if it all pans out the way I suspect. All in my humble opinion only.
Did you look at the pipeline Lampard? This girl ain't a short or medium term hold imo
FHI running phase 2 proof of concept. 80 individuals enrolled at later stage. DYOR
By that definition you're saying no one should invest in a single explorer across the market. If you are looking to do such a thing then risk vs MCAP here is really not too bad. And it's not in Timbuktu, it's in the US of A. Odd comments to post on an explorer really...
Well as usual the previous appearance of Aly yells and Criesagain signals an imminent rise. Just the grades to come now. Thank you our diligent cheerleaders!
Indeed indeed!
As a shareholder though updates are greatly appreciated over silence. Tailings and results to come. Great position and a paltry MCAP.
All in my humble opinion
Looks like analysis ongoing at the independent party. Not a single problem with the drilling so far, great pace being kept AND updating b shareholders as they go! Marvelous
Great work Paul. I was going to simply post that it was carri d out in Brazil therefore outside of the FDA regulatory area but simple message like that would have fallen on deaf ears. You can search the Brazilian hospital where the nasal trial is taking place. Here is the relevant excerpt fro Nov 2020.
"...scientific teams at the Harvard Medical School, Santa Casa de Misericórdia de Santos Hospital (Jabaquara, Santos, Brazil) and at Tiziana are closely collaborating to facilitate initiation of this study in expedited time frames. This clinical trial will be coordinated by the team at INTRIALS, a leading, full-service Latin America Clinical Research Organisation, (CRO) based in Sao Paulo City, Brazil. "
All the best everyone
Very round numbers Criesagain. Probably placing shares? Still think there's 20-30% to go. If you need the money to fill another lending contract then you obviously sell your assets to fill it. Good luck all
I'm sorry Bluebelly you're usually pretty good but now that is some real nonsense. If you couldn't afford to lose your entire investment in a share you shouldn't have invested, regardless of any dividend (yes AccuStem is a dividend). If you're gambling then the capital out is a problem. If you're investing then it's calculated and sensible. I too would buy as many AccuStem entitlements as I could right now off the whining traders currently present on this board. Perhaps TILS has worn you down BB and you need to move on? By the way, the Board of Directors owe shareholders nothing in any company.
All opinions and all the best.
jh Read my mind
Its coming. The first leg up. Good luck to all long term holders lets hope for great results.
I wish there was a way to lowball offer and buy the impatient out of their AccuStem shares. Shame
lol